- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06760754
Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net Hospital
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primary Objective:
Determine the feasibility of study recruitment goal, intervention adherence rate, attrition rate, data completion rate, and program satisfaction rate.
Secondary Objective:
Assess the preliminary efficacy of the digital culinary medicine intervention to improve diet quality, food security, quality of life, and downstream biological indicators of cardiometabolic health from baseline to post-intervention, as well as from baseline to 6 month follow up, among food insecure cancer survivors.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Maria Vazquez
- Phone Number: 713-792-7124
- Email: mrvazquez1@mdanderson.org
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Recruiting
- The University of Texas M. D. Anderson Cancer Center
-
Contact:
- Maria Vazquez
- Phone Number: 713-792-7124
- Email: mrvazquez1@mdanderson.org
-
Principal Investigator:
- Margaret Raber, DRPH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Cancer survivors treated at the MD Anderson Oncology Program at LBJ Hospital over 18 years of age.
- Screen positive for food insecurity using the 2 question clinic-screener (Hunger Vital Signs)
- Receive referral to the LBJ Food Farmacy.
- Are within the first 5 years off of acute cancer treatment.
- Self-report having internet access.
- Self-report as being able to speak and read English or Spanish.
- Willing to complete study assessments.
Exclusion Criteria:
- Unwilling or unable to complete study assessments
- Anyone under 18 years of age
- Self-report to not speak or read English or Spanish
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Usual Care Waitlist Control
Participants will be assessed for study eligibility and randomized to study
|
Participants will receive 30lbs of healthy foods through an on-site hospital-base food pantry
|
|
Experimental: Intervention Group
Participants will be assessed for study eligibility and randomized to study
|
Participants will receive 30lbs of healthy foods through an on-site hospital-base food pantry
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Safety and Adverse Events (AEs)
Time Frame: Through study completion; an average of 1 year
|
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
|
Through study completion; an average of 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Margaret Raber, DRPH, M.D. Anderson Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-1732
- NCI-2024-10265 (Other Identifier: NCI-CTRP Clinical Trials Registry)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
Morehouse School of MedicineRecruiting
Clinical Trials on Digital culinary medicine intervention
-
University of CalgaryCompleted
-
University of Texas Southwestern Medical CenterCompletedPrimary Disease: 1. Type 2 DiabetesUnited States
-
The University of Texas Health Science Center,...M.D. Anderson Cancer Center; National Cancer Institute (NCI)CompletedDiabetes | Elevated Body Mass IndexUnited States
-
The University of Texas Health Science Center,...Completed
-
Texas Tech UniversityCompletedSarcopeniaUnited States
-
Texas Tech UniversityNational Cattlemen's Beef AssociationCompletedSarcopeniaUnited States
-
MaineHealthCompletedFood Insecurity | Family Functioning | Nutrition | Family Function | Caregiver Stress | Food Insecurity Among Children | Child Mental Health | Caregiver Distress | Social Emotional Wellness | Caregiver Mental HealthUnited States
-
Clinica Universidad de Navarra, Universidad de...Completed
-
Clinica Universidad de Navarra, Universidad de...CompletedFamily ResearchSpain
-
Fondazione Don Carlo Gnocchi OnlusUniversity of Modena and Reggio Emilia; Centro Riabilitativo Villa Beretta; Istituto... and other collaboratorsRecruitingMultiple Sclerosis | Parkinson Disease | Neurologic Diseases, GeneralItaly